Clovis Oncology, Inc. Skyrocketed

Fri, Apr 01, 2022 at 05:30 PM
Clovis Oncology, Inc. Skyrocketed

Clovis Oncology, Inc. (CLVS:NASDAQ) jumped higher at $2.5, representing a gain of 23.8%. On Wed, Mar 30, 2022, CLVS:NASDAQ hit a New 2-Week Intraday High of $1.79. The stock appeared on our News Catalysts scanner on Thu, Mar 31, 2022 at 01:07 PM in the 'BIOTECH' category. From Wed, Mar 16, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days

The share price of the company has been moving sideways in recent weeks.

About Clovis Oncology, Inc. (CLVS:NASDAQ)

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.